3 No-Brainer Stocks to Buy in September
https://s.yimg.com/ny/api/res/1.2/UPruPMCw7VH2TVAWnWlz1g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/motleyfool.com/5cff340f76e5631aa9fc606ffb387b85
https://finance.yahoo.com/news/3-no-brainer-stocks-buy-113000544.html
The article discusses three healthcare stocks, Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals, that are considered no-brainer buys due to their strong growth prospects and potential for future success. Eli Lilly's tirzepatide drug has shown promising results in reducing the risk of type 2 diabetes, while Novo Nordisk's Ozempic and Wegovy drugs have seen rapid sales growth. Vertex Pharmaceuticals has a pipeline of promising drugs, including Casgevy, a CRISPR gene-editing therapy, and suzetrigine, a treatment for acute pain.